Are Readmissions After THA Preventable?

Clinical Orthopaedics and Related Research

Volumn 475, Issue 5, 2017, Pages 1414-1423

  Weinberg, Douglas S ^a   Kraay, Matthew J ^a   Fitzgerald, Steven J ^a   Sidagam, Vasu ^a   Wera, Glenn D ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL WITHDRAWAL SYNDROME; APPENDICITIS; ARTICLE; ATRIAL FIBRILLATION; CELLULITIS; CHOLELITHIASIS; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DEHYDRATION; DIVERTICULOSIS; ELECTIVE SURGERY; FEMALE; HEART INFARCTION; HEMATOMA; HIP DISLOCATION; HIP OSTEOARTHRITIS; HIP PAIN; HIP RADIOGRAPHY; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; ILEUS; INFECTIOUS ARTHRITIS; MALE; MEDICAL RECORD; MIDDLE AGED; NAUSEA; NEPHROLITHIASIS; PERIPROSTHETIC FRACTURE; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHESIS DISLOCATION; PROSTHESIS INFECTION; PROSTHETIC ALIGNMENT; RETROSPECTIVE STUDY; SEPSIS; SEROMA; SICKLE CELL CRISIS; SMALL INTESTINE OBSTRUCTION; SUBARACHNOID HEMORRHAGE; SURGICAL PATIENT; THORAX PAIN; TOTAL HIP PROSTHESIS; URINARY TRACT INFECTION; VAGINA BLEEDING; VERY ELDERLY; ADVERSE EFFECTS; COMORBIDITY; ELECTRONIC HEALTH RECORD; HEALTH CARE QUALITY; HIP REPLACEMENT; ODDS RATIO; OHIO; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; COMORBIDITY; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OHIO; PATIENT READMISSION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84994772044     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-016-5156-x     Document Type: Article

References (64)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: American Psychiatric Publishing; 2013.
2. Auerbach AD, Kripalani S, Vasilevskis EE, Sehgal N, Lindenauer PK, Metlay JP, Fletcher G, Ruhnke GW, Flanders SA, Kim C, Williams MV, Thomas L, Giang V, causes of readmissions in a national cohort of general medicine patients. JAMA Intern Med. 2016;176:484–493.
3. Avram V, Petruccelli D, Winemaker M, de Beer J. Total joint arthroplasty readmission rates and reasons for 30-day hospital readmission. J Arthroplasty. 2014;29:465–468.
4. Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000;160:1074–1081.
5. Biedermann R, Tonin A, Krismer M, Rachbauer F, Eibl G, Stockl B. Reducing the risk of dislocation after total hip arthroplasty: the effect of orientation of the acetabular component. J Bone Joint Surg Br. 2005;87:762–769.
6. Bohl DD, Shen MR, Kayupov E, Della Valle CJ. Hypoalbuminemia independently predicts surgical site infection, pneumonia, length of stay, and readmission after total joint arthroplasty. J Arthroplasty. 2016;31:15–21.
7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655.
8. Bosco JA 3rd, Karkenny AJ, Hutzler LH, Slover JD, Iorio R. Cost burden of 30-day readmissions following Medicare total hip and knee arthroplasty. J Arthroplasty. 2014;29:903–905.
9. Bozic KJ, Ward L, Vail TP, Maze M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res. 2014;472:188–193.
10. Clement RC, Derman PB, Graham DS, Speck RM, Flynn DN, Levin LS, Fleisher LA. Risk factors, causes, and the economic implications of unplanned readmissions following total hip arthroplasty. J Arthroplasty. 2013;28(8 suppl):7–10.
11. Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X, Wolf BR, Li Y. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA. 2011;305:1560–1567.
12. Cutrera NJ, Pinkas D, Toro JB. Surgical approaches to the acetabulum and modifications in technique. J Am Acad Orthop Surg. 2015;23:592–603.
13. Dailey EA, Cizik A, Kasten J, Chapman JR, Lee MJ. Risk factors for readmission of orthopaedic surgical patients. J Bone Joint Surg Am. 2013;95:1012–1019.
14. Department of Health and Human Services. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules. Federal Register. 2013;78:5565–5702.
15. Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE, Krumholz HM. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355–363.
16. Elmallah RK, Cherian JJ, Amin H, Jauregui JJ, Pierce TP, Mont MA. Readmission rates in patients who underwent total hip arthroplasty. Surg Technol Int. 2015;27:215–217.
17. Epstein AM. Revisiting readmissions: changing the incentives for shared accountability. N Engl J Med. 2009;360:1457–1459.
18. Fischer C, Lingsma HF, Marang-van de Mheen PJ, Kringos DS, Klazinga NS, Steyerberg EW. Is the readmission rate a valid quality indicator? A review of the evidence. PLoS One. 2014;9:e112282.
19. Gofton W, Chow J, Olsen KD, Fitch DA. Thirty-day readmission rate and discharge status following total hip arthroplasty using the supercapsular percutaneously-assisted total hip surgical technique. Int Orthop. 2015;39:847–851.
20. Halawi MJ, Vovos TJ, Green CL, Wellman SS, Attarian DE, Bolognesi MP. Current evidence does not support Medicare’s 3-day rule in primary total joint arthroplasty. Am J Orthop (Belle Mead NJ). 2015;44:E370–372.
21. Hawk PB. Ready or not: hospital value-based purchasing poised to transform healthcare reimbursement model and introduce new fraud targets under the False Claims Act. Annals Health Law. 2013;22:43.
22. Healy WL, Iorio R, Clair AJ, Pellegrini VD, Della Valle CJ, Berend KR. Complications of total hip arthroplasty: standardized list, definitions, and stratification developed by The Hip Society. Clin Orthop Relat Res. 2016;474:357–364.
23. Hechenbleikner EM, Makary MA, Samarov DV, Bennett JL, Gearhart SL, Efron JE, Wick EC. Hospital readmission by method of data collection. J Am Coll Surg. 2013;216:1150–1158.
24. Huddleston JI, Wang Y, Uquillas C, Herndon JH, Maloney WJ. Age and obesity are risk factors for adverse events after total hip arthroplasty. Clin Orthop Relat Res. 2012;470:490–496.
25. Issa K, Pivec R, Wuestemann T, Tatevossian T, Nevelos J, Mont MA. Radiographic fit and fill analysis of a new second-generation proximally coated cementless stem compared to its predicate design. J Arthroplasty. 2014;29:192–198.
26. Jain N, Johnson T, Morehouse L, Rogers S, Guleri A, Dunkow P. MRSA & MSSA screening for elective lower limb arthroplasty. Bone Joint J Orthop Proc Suppl. 2013;95:205.
27. Jorgensen CC, Petersen MA, Kehlet H; Lundbeck Foundation Centre for Fast-Track Hip and Knee Replacement Collaborative Group. Preoperative prediction of potentially preventable morbidity after fast-track hip and knee arthroplasty: a detailed descriptive cohort study. BMJ Open. 2016;6:e009813.
28. Joynt KE, Jha AK. Thirty-day readmissions: truth and consequences. N Engl J Med. 2012;366:1366–1369.
29. Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013;309:342–343.
30. Keeney JA, Adelani MA, Nunley RM, Clohisy JC, Barrack RL. Assessing readmission databases: how reliable is the information? J Arthroplasty. 2012;27(8 suppl):72–76.e1-2.
31. Keeney JA, Nam D, Johnson SR, Nunley RM, Clohisy JC, Barrack RL. The impact of risk reduction initiatives on readmission: THA and TKA readmission rates. J Arthroplasty. 2015;30:2057–2060.
32. Keswani A, Lovy AJ, Robinson J, Levy R, Chen D, Moucha CS. Risk factors predict increased length of stay and readmission rates in revision joint arthroplasty. J Arthroplasty. 2016;31:603–608.
33. Kiridly DN, Karkenny AJ, Hutzler LH, Slover JD, Iorio R, Bosco JA 3rd. The effect of severity of disease on cost burden of 30-day readmissions following total joint arthroplasty (TJA). J Arthroplasty. 2014;29:1545–1547.
34. Kurtz SM, Lau EC, Baykal D, Springer BD. Outcomes of ceramic bearings after revision total hip arthroplasty in the Medicare population. J Arthroplasty. 2016;31:1979–1985.
35. Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Which hospital and clinical factors drive 30- and 90-day readmission after TKA? J Arthroplasty. 2016;31:2099–2107.
36. Lavernia CJ, Villa JM, Iacobelli DA. Readmission rates in the state of Florida: a reflection of quality? Clin Orthop Relat Res. 2013;471:3856–3862.
37. Lewinnek GE, Lewis JL, Tarr R, Compere CL, Zimmerman JR. Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978;60:217–220.
38. Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95:1801–1811.
39. Lim SJ, Yeo I, Park CW, Moon YW, Park YS. Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia. BMC Musculoskelet Disord. 2015;16:278.
40. Martsolf GR, Barrett ML, Weiss AJ, Kandrack R, Washington R, Steiner CA, Mehrotra A, SooHoo NF, Coffey R. Impact of race/ethnicity and socioeconomic status on risk-adjusted hospital readmission rates following hip and knee arthroplasty. J Bone Joint Surg Am. 2016;98:1385–1391.
41. McNair PD, Luft HS, Bindman AB. Medicare’s policy not to pay for treating hospital-acquired conditions: the impact. Health Aff (Millwood). 2009;28:1485–1493.
42. Ninomiya JT, Dean JC, Incavo SJ. What’s new in hip replacement. J Bone Joint Surg Am. 2015;97:1543–1551.
43. Nouraie M, Gordeuk VR. Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis. Transfusion. 2015;55:2331–2338.
44. Oronce CI, Shao H, Shi L. Disparities in 30-day readmissions after total hip arthroplasty. Med Care. 2015;53:924–930.
45. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does “excessive” anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007;22(6 suppl 2):24–28.
46. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–2994.
47. Paxton EW, Inacio MC, Singh JA, Love R, Bini SA, Namba RS. Are there modifiable risk factors for hospital readmission after total hip arthroplasty in a US healthcare system? Clin Orthop Relat Res. 2015;473:3446–3455.
48. Plate JF, Brown ML, Wohler AD, Seyler TM, Lang JE. Patient factors and cost associated with 90-day readmission following total hip arthroplasty. J Arthroplasty. 2016;31:49–52.
49. Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplasty. 2013;28:1499–1504.
50. Ramkumar PN, Chu CT, Harris JD, Athiviraham A, Harrington MA, White DL, Berger DH, Naik AD, Li LT. Causes and rates of unplanned readmissions after elective primary total joint arthroplasty: a systematic review and meta-analysis. Am J Orthop (Belle Mead NJ). 2015;44:397–405.
51. Saucedo J, Marecek GS, Lee J, Huminiak L, Stulberg SD, Puri L. How accurately are we coding readmission diagnoses after total joint arthroplasty? J Arthroplasty. 2013;28:1076–1079.
52. Schairer WW, Sing DC, Vail TP, Bozic KJ. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res. 2014;472:464–470.
53. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso JN Jr, McCullough DL. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi: the American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. 1994;151:1648–1651.
54. Sellers MM, Merkow RP, Halverson A, Hinami K, Kelz RR, Bentrem DJ, Bilimoria KY. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216:420–427.
55. Sibia US, Mandelblatt AE, Callanan MA, MacDonald JH, King PJ (2016) Incidence, risk factors, and costs for hospital returns after total joint arthroplasties. J Arthroplasty. DOI: 10.1016/j.arth.2016.08.003.
56. Silen W, Cope Z. Cope’s Early Diagnosis of the Acute Abdomen. New York, NY: Oxford University Press, USA; 2005.
57. Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults: Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:3110–3121.
58. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–498; quiz 499.
59. van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a systematic review. CMAJ. 2011;183:E391–402.
60. Voskuijl T, Hageman M, Ring D. Higher Charlson comorbidity index scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res. 2014;472:1638–1644.
61. Watts CD, Houdek MT, Wagner ER, Lewallen DG, Mabry TM. Morbidly obese vs nonobese aseptic revision total hip arthroplasty: surprisingly similar outcomes. J Arthroplasty. 2016;31:842–845.
62. Wera GD, Ting NT, Moric M, Paprosky WG, Sporer SM, Della Valle CJ. Classification and management of the unstable total hip arthroplasty. J Arthroplasty. 2012;27:710–715.
63. Yu S, Garvin KL, Healy WL, Pellegrini VD Jr, Iorio R. Preventing hospital readmissions and limiting the complications associated with total joint arthroplasty. J AmAcad Orthop Surg. 2015;23:e60–71.
64. Zmistowski B, Restrepo C, Hess J, Adibi D, Cangoz S, Parvizi J. Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors. J Bone Joint Surg Am. 2013;95:1869–1876.